A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer

INTRODUCTION. Bevacizumab is increasingly being tested with neoadjuvant regimens in patients with localized cancer, but its effects on metastasis and survival remain unknown. This study examines the long-term outcome of clinical stage II/III rectal cancer patients treated in a prospective phase II s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Willett, Christopher G., Duda, Dan G., Ancukiewicz, Marek, Shah, Mira, Czito, Brian G., Bentley, Rex, Poleski, Martin, Fujita, Hiroshi, Lauwers, Gregory Y., Carroll, Madeline, Tyler, Douglas, Mantyh, Christopher, Shellito, Paul, Chung, Daniel C., Clark, Jeffrey W., Jain, Rakesh K.
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2010
Teme:
Gastrointestinal Cancer
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3078712/
https://ncbi.nlm.nih.gov/pubmed/20667969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0030
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items